By Industry Desk | May 8, 2026 In a move that cements its status as a cornerstone...
Chemotherapy and Targeted Therapy
A groundbreaking retrospective study published in the journal Pharmaceuticals reveals that patients with atherosclerotic cardiovascular disease (ASCVD)...
Published: May 11, 2026 The biotechnology landscape experienced a week of significant volatility and strategic realignment, marked...
A Breakthrough in Cardiovascular Research A recent study published in the journal Pharmaceuticals (Vol. 19, No. 5)...
In a remarkable convergence of reproductive biology and ophthalmological innovation, researchers have pioneered a non-invasive treatment for...
In the high-stakes arena of modern biopharmaceutical manufacturing, the traditional metrics of site selection—primarily tax rates and...
In a major development for global ophthalmology, a comprehensive, multicenter study has provided robust real-world evidence confirming...
In 2024, OpenAI CEO Sam Altman posited a bold, futuristic vision: a lone entrepreneur, armed with the...
In the high-stakes world of pharmaceutical development, the emergence of biosimilars—medicinal products designed to be highly similar...
For over a century, the pharmaceutical industry has flirted with the concept of "covalent bonding"—the creation of...
